Public Sector Pension Investment Board Has $12.11 Million Position in Balchem Co. (NASDAQ:BCPC)

Public Sector Pension Investment Board lowered its stake in shares of Balchem Co. (NASDAQ:BCPC) by 3.5% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 68,812 shares of the basic materials company’s stock after selling 2,500 shares during the quarter. Public Sector Pension Investment Board owned about 0.21% of Balchem worth $12,111,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in BCPC. nVerses Capital LLC acquired a new stake in Balchem during the third quarter worth approximately $35,000. GAMMA Investing LLC boosted its holdings in shares of Balchem by 73.4% in the 3rd quarter. GAMMA Investing LLC now owns 841 shares of the basic materials company’s stock valued at $148,000 after purchasing an additional 356 shares in the last quarter. Blue Trust Inc. boosted its holdings in shares of Balchem by 642.5% in the 3rd quarter. Blue Trust Inc. now owns 839 shares of the basic materials company’s stock valued at $148,000 after purchasing an additional 726 shares in the last quarter. TD Asset Management Inc acquired a new stake in shares of Balchem in the 2nd quarter valued at $200,000. Finally, Heritage Family Offices LLP acquired a new stake in shares of Balchem in the 2nd quarter valued at $206,000. Institutional investors and hedge funds own 87.91% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on BCPC shares. StockNews.com raised Balchem from a “hold” rating to a “buy” rating in a report on Monday, October 28th. HC Wainwright increased their price target on Balchem from $185.00 to $190.00 and gave the company a “buy” rating in a research note on Monday, November 4th.

Balchem Stock Down 1.4 %

Shares of BCPC opened at $179.69 on Friday. Balchem Co. has a 52 week low of $120.87 and a 52 week high of $186.03. The stock has a market capitalization of $5.84 billion, a price-to-earnings ratio of 48.30, a PEG ratio of 5.46 and a beta of 0.65. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.90 and a current ratio of 2.98. The stock has a fifty day moving average of $174.30 and a 200-day moving average of $167.17.

Balchem Company Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.